🇺🇸 L-leucovorin in United States

106 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Non-Hodgkin^S Lymphoma Recurrent — 27 reports (25.47%)
  2. Disease Progression — 15 reports (14.15%)
  3. Neutropenia — 13 reports (12.26%)
  4. Diarrhoea — 9 reports (8.49%)
  5. Anaemia — 7 reports (6.6%)
  6. Decreased Appetite — 7 reports (6.6%)
  7. Fatigue — 7 reports (6.6%)
  8. Leukopenia — 7 reports (6.6%)
  9. Nausea — 7 reports (6.6%)
  10. Stomatitis — 7 reports (6.6%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is L-leucovorin approved in United States?

L-leucovorin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for L-leucovorin in United States?

Gruppo Oncologico del Nord-Ovest is the originator. The local marketing authorisation holder may differ — check the official source linked above.